David Sidransky's Net Worth

$4.95 Million

Estimate Recalculated Jun 4, 2024 03:51PM EST

Who is David Sidransky?

David Sidransky has an estimated net worth of $4.95 Million. This is based on reported shares across multiple companies, which include Tamir Biotechnology, Inc., KV PHARMACEUTICAL CO /DE/, CHAMPIONS ONCOLOGY, INC., Cactus Acquisition Corp. 1 Ltd, Celsus Therapeutics Plc., Ayala Pharmaceuticals, Inc., Orgenesis Inc., Old Ayala, Inc, IMMUNE PHARMACEUTICALS INC, IMCLONE SYSTEMS INC/DE, and ZILA INC.

SEC CIK

David Sidransky's CIK is 0001277161

Past Insider Trading and Trends

2020 was David Sidransky's most active year for acquiring shares with 16 total transactions. David Sidransky's most active month to acquire stocks was the month of October. 2023 was David Sidransky's most active year for disposing of shares, totalling 3 transactions. David Sidransky's most active month to dispose stocks was the month of September. 2018 saw David Sidransky paying a total of $133,061.07 for 126,733 shares, this is the most they've acquired in one year. In 2016 David Sidransky cashed out on 22,808 shares for a total of $342,348.08, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Tamir Biotechnology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jul 23
Form 4
0
0
Jun 6
Form 4
0
0
Apr 28
Form 4
0
0
Dec 31
Form 4
0
0
Dec 31
Form 4
0
0
Feb 8
Form 4
0
0
Dec 31
Form 4
+12.50%
5K
$3.46
$17,300.00
45K
Mar 7
Form 4
0
0
Dec 31
Form 4
0
0
Dec 31
Form 3
0
0
Form 4
0
0
May 28
No matching records found

KV PHARMACEUTICAL CO /DE/ No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
0
0
Jul 2
Form 3
0
0
No matching records found

CHAMPIONS ONCOLOGY, INC. (CSBR) Snapshot price: $6.072

Chairman the Board

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Nov 3
Form 4
0
0
Nov 1
Form 4
+0.63%
4.77K
$5.36
-$1.69
767.04K
Oct 12
Form 4
0
0
Nov 5
Form 4
+2.58%
19.3K
$2.75
$53,000.85
762.27K
Oct 15
Form 4
0
0
Dec 8
Form 4
+0.89%
6.57K
$7.24
$0.82
748.23K
Oct 16
Form 4
0
0
Nov 4
Form 4
0
0
Nov 1
Form 4
0
0
Nov 1
Form 4
0
0
Nov 2
Form 4
0
0
Oct 13
Form 4
0
0
Dec 12
Form 4
+0.95%
100K
10.68M
Jul 14
Form 4
0
0
Feb 22
Form 4
0
0
Aug 28
Form 4
0
0
Mar 31
Form 4
+54.29%
3.8M
10.8M
May 17
Form 3
0
0
No matching records found

Cactus Acquisition Corp. 1 Ltd (CCTS) Snapshot price: $11.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

Celsus Therapeutics Plc. (AKTX) Snapshot price: $2.94

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found